Erin Hodson Vice President Revenue Cycle Inova Achievements: Major Wins and Leadership Impact

Four days before this article was prepared, Inova Health disclosed another major step in its revenue-cycle strategy. A new collaboration with Anomaly Insights identified $10.4 million in recovered-revenue opportunities during its first 90 days, with an estimated $3.8 million in continuing monthly revenue impact, according to the September 10, 2026 announcement.

That development puts fresh attention on Erin Hodson, MSN, Vice President of Revenue Cycle at Inova Health, whose responsibilities stretch across an organization serving more than one million unique patients annually. Inova says its network records more than four million patient visits per year and employs approximately 26,000 team members.

The significance goes beyond hospital billing. Revenue-cycle failures can delay reimbursement, consume clinical staff time and create confusing financial experiences for patients. Hodson’s tenure has increasingly centered on moving Inova from reacting to those problems toward predicting them, identifying payer-specific patterns and fixing weaknesses before they become recurring losses.

BLUF: Erin Hodson is Inova Health’s Vice President of Revenue Cycle, leading an organization of roughly 1,500 people. Her documented achievements include helping drive approximately $100 million in reported net-revenue gains, reducing revenue leakage, advancing AI-supported workflows and pushing Inova toward proactive, data-driven denial prevention.

The numbers that put Hodson’s Inova work on the national radar

Hodson entered Inova’s top revenue-cycle position in 2024 after years in clinical operations and hospital leadership. Her move was unusual because revenue cycle was not simply another extension of her prior operating portfolio; it represented a shift into a heavily financial, technology-dependent function working under Inova’s finance organization. Becker’s reported her appointment in June 2024, noting that she had previously served as vice president and administrator for Inova’s medicine service line.

Within roughly a year, Becker’s Healthcare placed Hodson on its 2025 Health IT & Revenue Cycle Up-and-Comers list. The publication attributed several specific outcomes to her leadership: alignment across Inova’s five hospitals and medical group, work with Impact Advisors, and approximately $100 million in net-revenue gains associated with denial management, accounts-receivable reduction and hierarchical condition category recapture. Becker’s also credited her with data-driven improvements spanning coding, billing and patient access.

Those figures matter because they describe more than increased collections. They point to a restructuring of how separate revenue-cycle functions interact.

Documented area	Reported development
Executive role	Vice President of Revenue Cycle, Inova Health
Revenue-cycle workforce	About 1,500 people
Health-system scope	Five hospitals plus Inova medical group and broader care network
Reported financial impact	Approximately $100 million in net-revenue gains cited by Becker’s in 2025
Core improvement areas	Denials, accounts receivable, HCC recapture, coding, billing and patient access
AI/utilization initiative	Xsolis Dragonfly deployed in December 2024
Latest payer-intelligence result	$10.4 million in recovered-revenue opportunities identified during first 90 days
Estimated continuing impact from latest initiative	$3.8 million monthly, according to the September 2026 partnership announcement
Industry recognition	Becker’s 2025 Health IT & Revenue Cycle Up-and-Comers

The approximately $100 million figure should be understood as a reported outcome associated with the broader transformation, not as Hodson’s personal compensation or an independently audited measure attributable to one individual. Large health-system improvements depend on extensive clinical, finance, technology, managed-care and revenue-cycle teams.

Her path to revenue cycle started far from hospital billing

Hodson’s career history helps explain why her approach has emphasized operations rather than treating revenue cycle as an isolated finance department.

According to the University of Virginia’s Darden School of Business, she began her career as a business consultant at Arthur Andersen before changing direction and attending nursing school. She worked at Shepherd Center in Atlanta while studying, later became a nurse educator and eventually moved into care-management-related work.

After joining Inova, she advanced through increasingly large operational assignments. Her experience included care-management leadership, senior director responsibilities at Inova Fairfax, leadership of Inova Children’s Hospital, adult hospital leadership at Inova Fairfax Medical Campus and oversight connected with emergency, medicine and critical-care services.

That clinical-operational foundation is relevant to revenue cycle because reimbursement rarely begins with a bill. Patient registration, authorization, documentation, level-of-care decisions, coding and clinical workflows can all influence whether a claim is accepted, delayed, reduced or denied.

The strategic shift: stop appealing every denial and start predicting the payer

One of the clearest themes in Hodson’s recent work is the attempt to move denial management upstream.

In July 2026, Becker’s asked healthcare revenue-cycle leaders to identify initiatives producing their strongest results. Hodson described Inova’s effort to use data to examine payer-specific denial and payment-retraction patterns rather than merely automating existing workflows. She reported that the organization had identified multimillion-dollar payment retractions, reached some of its lowest hospital and professional denial rates and persuaded a national payer to remove an edit responsible for more than $1 million in denials.

That is an important distinction. Traditional denial management can resemble cleanup: a claim is rejected, staff investigate the reason, documentation is gathered and an appeal follows. Hodson’s stated model aims to spot recurring payer behavior earlier and challenge the underlying mechanism.

The September 2026 Anomaly collaboration extends that strategy. The partnership gives Inova’s revenue-cycle and managed-care teams analytics designed to evaluate payer behavior and payment outcomes. The first 90 days produced the reported $10.4 million in recovered-revenue opportunities, alongside the estimated $3.8 million monthly impact.

The strongest evidence of Hodson’s strategy is not simply that Inova is automating work. It is that the organization is increasingly using data to determine why money is being denied, reduced or reclaimed—and then attempting to change the underlying process.

AI moved from an experiment to an operating tool

Hodson’s technology strategy can also be seen in Inova’s work with Xsolis.

Inova implemented the company’s Dragonfly platform in December 2024 to strengthen utilization-management workflows and make case prioritization more data-driven. Becker’s reported that the system evaluates clinical information from the electronic medical record to assist with real-time level-of-care decisions.

By October 2025, Inova leaders reported that 80% of cases were being reviewed within the first 24 hours, while the organization said it had improved its observation-rate management and reimbursement alignment. Hodson highlighted technology’s ability to quantify denial-prevention opportunities continuously rather than waiting for problems to appear downstream.

Her broader comments also reveal how she sees artificial intelligence changing staffing. In late 2025, she told Becker’s that revenue-cycle teams would increasingly need to understand complex denial patterns, work alongside AI agents and develop capabilities for roles that had barely existed previously.

The emerging model is therefore not simply “replace people with AI.” It requires people capable of supervising automation, interpreting payer behavior, investigating exceptions and deciding when human judgment should override automated recommendations.

A 12-month transformation combined technology with cultural change

Another significant project paired Inova with Impact Advisors on a systemwide revenue-cycle optimization program.

Scottsdale Institute described the work as a 12-month transformation involving a five-hospital system, more than 250 care sites and approximately 25,000 team members at the time the event materials were prepared. The program addressed changing payer requirements, increasingly difficult denials and opportunities to bring Epic configuration closer to foundational best practices.

Impact Advisors later said the initiative combined Epic optimization with operational and cultural changes, including stronger denial management, improved patient financial engagement, automated claims follow-up and more actionable reporting. Its public summary stated that Inova exceeded the program’s financial-improvement goal by $27 million.

The emphasis on culture is particularly relevant to Hodson’s management philosophy. UVA Darden reported that she entered revenue cycle after completing its Executive Program and credited that experience with strengthening her understanding of financial modeling, strategy and enterprise-level decision-making.

Key points in the public timeline

• 2011: Hodson was already beginning what would become a long Inova leadership career, according to Becker’s and UVA Darden accounts.
• 2015–2016: Inova publications identified her as Vice President and Administrator of Inova Children’s Hospital during the development and opening period of the expanded children’s facility.
• 2023–2024: She participated in Darden’s Executive Program after broad operational leadership and work on an Inova joint venture.
• June 2024: Becker’s reported her appointment as Inova’s Vice President of Revenue Cycle.
• December 2024: Inova implemented Xsolis’ Dragonfly platform for AI-supported utilization-management work.
• August 2025: Becker’s named Hodson among its Health IT & Revenue Cycle Up-and-Comers and reported roughly $100 million in gains linked to broader transformation efforts.
• July 2026: Hodson publicly described Inova’s shift toward payer-behavior analytics and denial prevention, including removal of a payer edit associated with more than $1 million in denials.
• September 10, 2026: The Anomaly-Inova collaboration publicly reported $10.4 million in recovered-revenue opportunities identified during its first 90 days.

Why her achievements matter beyond Inova’s finance department

Revenue cycle can sound remote from patient care because many of its activities occur after clinical encounters. In practice, financial operations touch nearly every stage of the patient experience.

An authorization problem can delay treatment. Poor documentation can make reimbursement harder to secure. A billing error can confuse a family. An inaccurate denial can force clinicians and administrative employees to spend hours correcting something that should have been resolved correctly the first time.

Hodson’s strategy connects these operational problems to Inova’s nonprofit mission. In the September 2026 announcement, she explicitly linked recovered revenue to reinvestment in patients and communities. Inova describes itself as Northern Virginia’s leading nonprofit healthcare provider, serving more than one million unique patients each year.

This is also why payer intelligence has become strategically important. A health system processing enormous numbers of encounters cannot sustainably investigate every pattern manually. Better analytics can highlight unusual denials, payment discrepancies or recurring contract problems that would otherwise be difficult to detect at scale.

The bigger signal in Hodson’s record

The most revealing feature of Erin Hodson’s revenue-cycle tenure is not one financial number.

It is the operating philosophy connecting those numbers.

Her public record shows a progression from clinical care and hospital operations into finance-heavy enterprise leadership, followed by efforts to connect departments that historically operated separately. Coding, utilization management, billing, patient access, managed care, denials and data science increasingly become parts of one financial system rather than isolated teams.

The September 2026 Anomaly results push that strategy further. Instead of waiting until a payer denies or retracts payment, Inova is attempting to identify patterns early enough to challenge them systematically. Combined with the approximately $100 million in gains previously reported by Becker’s, the Impact Advisors transformation and AI-supported utilization-management work, Hodson’s achievements point toward a revenue-cycle model built around prediction, prevention, automation and cross-functional accountability.

For hospitals facing increasing administrative complexity, that may be the most important part of the story: revenue-cycle leadership is becoming less about processing claims after care and more about understanding every operational decision that determines whether appropriate reimbursement reaches the health system in the first place.

FAQs

Who is Erin Hodson?

Erin Hodson is the Vice President of Revenue Cycle at Inova Health. Her professional history combines business consulting, nursing, care management and senior healthcare operations. She moved into Inova’s revenue-cycle leadership role in 2024 after holding several executive positions within the health system.

What are Erin Hodson’s biggest documented achievements at Inova?

Her documented achievements include leading revenue-cycle transformation across Inova, supporting data-driven changes in coding, billing and patient access, advancing denial-prevention strategies and promoting AI-enabled workflows. Becker’s reported approximately $100 million in net-revenue gains associated with a broader initiative involving denial management, accounts receivable and HCC recapture.

How large is Erin Hodson’s revenue-cycle team?

UVA Darden reported in March 2025 that Hodson was responsible for approximately 1,500 people in her revenue-cycle role. That scale places her in charge of a substantial enterprise function operating across Inova’s hospitals, medical group and connected revenue-cycle activities.

How is Erin Hodson using AI in revenue cycle management?

Hodson’s strategy uses AI and data analytics for purposes including utilization management, workflow optimization, denial prevention and payer-behavior analysis. Inova has worked with technology partners including Xsolis and Anomaly Insights while also exploring automation and Epic-based improvements across its revenue-cycle operation.

Did Erin Hodson help Inova recover $10.4 million?

The September 10, 2026 Anomaly-Inova announcement says Inova identified $10.4 million in recovered-revenue opportunities during the first 90 days of the collaboration. It also reported an estimated $3.8 million in continuing monthly impact. Those figures describe organizational opportunities generated through the partnership rather than money attributable solely to one executive.

What recognition has Erin Hodson received for her revenue-cycle work?

Becker’s Healthcare included Hodson in its 2025 Health IT & Revenue Cycle Up-and-Comers list. Inova publicly highlighted that recognition and credited her with breaking down departmental silos and advancing data-driven and AI-supported improvements across coding, billing and patient access.

Editorial Disclaimer

This article uses publicly available institutional statements, professional profiles, healthcare-industry reporting and event materials available as of September 14, 2026. Financial figures describe results or opportunities reported by the cited organizations and publications; they should not be interpreted as independently audited figures or as outcomes attributable solely to Erin Hodson. No unsupported estimates of personal wealth, compensation or private financial assets have been included.

Businessbiohub.com